{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:37:37Z","timestamp":1778614657026,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jns.2025.123470","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T16:54:14Z","timestamp":1742403254000},"page":"123470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Treatments and therapies for symptoms and clinical manifestations of adult type 1 myotonic dystrophy: A scoping review"],"prefix":"10.1016","volume":"472","author":[{"given":"Alexandra Victoria Rose","family":"Childs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert David","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel James","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana Yvette","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Szollosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.123470_bb0005","series-title":"Myotonic Dystrophy","author":"Harper","year":"2009"},{"key":"10.1016\/j.jns.2025.123470_bb0010","series-title":"Global Prevalence of Myotonic Dystrophy: An Updated Systematic Review and Meta-Analysis","author":"Liao","year":"2022"},{"key":"10.1016\/j.jns.2025.123470_bb0015","series-title":"Molecular Basis of Myotonic Dystrophy: Expansion of a Trinucleotide (CTG) Repeat at the 3\u2032 End of a Transcript Encoding a Protein Kinase Family Member","author":"Brook","year":"1992"},{"key":"10.1016\/j.jns.2025.123470_bb0020","series-title":"Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy","author":"Buxton","year":"1992"},{"key":"10.1016\/j.jns.2025.123470_bb0025","series-title":"Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy","author":"Harley","year":"1992"},{"key":"10.1016\/j.jns.2025.123470_bb0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","article-title":"Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms","volume":"1852","author":"Meola","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.jns.2025.123470_bb0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fneur.2018.00303","article-title":"Core clinical phenotypes in myotonic dystrophies","volume":"9","author":"Wenninger","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2025.123470_bb0040","series-title":"Instability of a premutation allele in homozygous patients with myotonic dystrophy type","volume":"1","author":"Abbruzzese","year":"2002"},{"key":"10.1016\/j.jns.2025.123470_bb0045","series-title":"A 10-Year Study of Mortality in a Cohort of Patients with Myotonic Dystrophy","author":"Mathieu","year":"1999"},{"key":"10.1016\/j.jns.2025.123470_bb0050","series-title":"Age and causes of death in adult-onset myotonic dystrophy","author":"De Die-Smulders","year":"1998"},{"key":"10.1016\/j.jns.2025.123470_bb0055","series-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type","volume":"1","author":"Groh","year":"2008"},{"key":"10.1016\/j.jns.2025.123470_bb0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jns.2017.08.753","article-title":"Prognosis and causes of death in myotonic dystrophy type 1 in our hospital","volume":"381","author":"Aburakawa","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2025.123470_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11940-016-0434-1","article-title":"Myotonic Dystrophy type 1 management and therapeutics","volume":"18","author":"Smith","year":"2016","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jns.2025.123470_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/CPJ.0000000000000531","article-title":"Consensus-based care recommendations for adults with myotonic dystrophy type 1","volume":"8","author":"Ashizawa","year":"2018","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jns.2025.123470_bb0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/WCO.0000000000000591","article-title":"Towards clinical outcome measures in myotonic dystrophy type 2: a systematic review","volume":"31","author":"Rastelli","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2025.123470_bb0080","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s13311-018-00679-z","article-title":"Myotonic dystrophies: targeting therapies for multisystem disease","volume":"15","author":"LoRusso","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jns.2025.123470_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/ijms21020457","article-title":"DM1 phenotype variability and triplet repeat instability: challenges in the development of new therapies","volume":"21","author":"Tom\u00e9","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2025.123470_bb0090","series-title":"Psychological characteristics of patients with myotonic dystrophy type","volume":"1","author":"Bertrand","year":"2015"},{"key":"10.1016\/j.jns.2025.123470_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185866","article-title":"Psychological factors influencing adherence to NIV in neuromuscular patients dependent on non invasive mechanical ventilation: preliminary results","volume":"12","author":"Annunziata","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jns.2025.123470_bb0100","series-title":"The myotonic dystrophy experience: a North American cross-sectional study","author":"Hagerman","year":"2019"},{"key":"10.1016\/j.jns.2025.123470_bb0105","series-title":"La variabilit\u00e9 du ph\u00e9notype dans la dystrophie myotonique de Steinert","author":"Bouchard","year":"1989"},{"issue":"PRISM-1","key":"10.1016\/j.jns.2025.123470_bb0110","article-title":"Patient-reported impact of symptoms in myotonic dystrophy type","volume":"1","author":"Heatwole","year":"2012"},{"key":"10.1016\/j.jns.2025.123470_bb0115","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/mus.24440","article-title":"Phenotypic variability and molecular genetics in proximal myotonic myopathy","volume":"51","author":"Papadimas","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2025.123470_bb0120","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1179\/1743132815Y.0000000068","article-title":"Variability of multisystemic features in myotonic dystrophy type 1--lessons from Serbian registry","volume":"37","author":"Rakocevic-Stojanovic","year":"2015","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jns.2025.123470_bb0125","series-title":"The DM-scope registry: A rare disease innovative framework bridging the gap between research and medical care","author":"De Antonio","year":"2019"},{"key":"10.1016\/j.jns.2025.123470_bb0130","series-title":"Understanding people with Steinert\u2019s disease to better care for them","author":"Lecordier","year":"2017"},{"key":"10.1016\/j.jns.2025.123470_bb0135","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"10.1016\/j.jns.2025.123470_bb0140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2025.123470_bb0145","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","article-title":"The well-built clinical question: a key to evidence-based decisions","volume":"123","author":"Richardson","year":"1995","journal-title":"ACP J. Club"},{"key":"10.1016\/j.jns.2025.123470_bb0150","author":"CADTH"},{"key":"10.1016\/j.jns.2025.123470_bb0155","first-page":"54","article-title":"Development and usage growth of the polyglot search translator","volume":"1","author":"Clark","year":"2020","journal-title":"J. Health Inf. Libr. Australas."},{"key":"10.1016\/j.jns.2025.123470_bb0160","series-title":"Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update","author":"Saldanha","year":"2022"},{"key":"10.1016\/j.jns.2025.123470_bb0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF01671719","article-title":"On the clinical and anatomical picture of myotonic muscle weakening","volume":"37","author":"Steinert","year":"1909","journal-title":"Dtsch. Z. Nervenheilkd."},{"key":"10.1016\/j.jns.2025.123470_bb0170","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neurol.2016.08.003","article-title":"Unravelling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study with implications for disease classification","volume":"172","author":"De Antonio","year":"2016","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jns.2025.123470_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/ane.12356","article-title":"Psychological characteristics of patients with myotonic dystrophy type 1","volume":"132","author":"Bertrand","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2025.123470_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00439-005-1298-8","article-title":"Anatomy of a founder effect: myotonic dystrophy in northeastern Quebec","volume":"117","author":"Yotova","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.jns.2025.123470_bb0185","series-title":"Eight years after an international workshop on myotonic dystrophy patient registries: Case study of a global collaboration for a rare disease","author":"Wood","year":"2018"},{"key":"10.1016\/j.jns.2025.123470_bb0190","series-title":"Multiple Case Study of Changes in Participation of Adults with Myotonic Dystrophy Type 1: Importance of Redesigning Accomplishment and Resilience","author":"Raymond","year":"2022"},{"key":"10.1016\/j.jns.2025.123470_bb0195","series-title":"Health supervision and anticipatory guidance in adult myotonic dystrophy type","volume":"1","author":"Gagnon","year":"2010"},{"key":"10.1016\/j.jns.2025.123470_bb0200","series-title":"Picturing the Experience of Living with Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice","author":"LaDonna","year":"2015"},{"key":"10.1016\/j.jns.2025.123470_bb0205","series-title":"Truths and misinformation: a qualitative exploration of myotonic dystrophy","author":"LaDonna","year":"2015"},{"issue":"DM1","key":"10.1016\/j.jns.2025.123470_bb0210","article-title":"New nomenclature and DNA testing guidelines for myotonic dystrophy type","volume":"vol. 1","author":"Ashizawa","year":"2000"},{"key":"10.1016\/j.jns.2025.123470_bb0215","series-title":"Evolving Motivations: Patients\u2019 and Caregivers\u2019 Perceptions about Seeking Myotonic Dystrophy (DM1) and Huntington\u2019s Disease Care","author":"LaDonna","year":"2017"},{"key":"10.1016\/j.jns.2025.123470_bb0220","series-title":"Uncovering health and social care needs among myotonic dystrophy patients: Utility of the Needs and Provisions Complexity Scale","author":"Holm\u00f8y","year":"2019"},{"key":"10.1016\/j.jns.2025.123470_bb0225","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.chest.2017.12.018","article-title":"The challenge of rare diseases","volume":"153","author":"Stoller","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jns.2025.123470_bb0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13023-017-0755-5","article-title":"An overview of the impact of rare disease characteristics on research methodology","volume":"13","author":"Whicher","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2025.123470_bb0235","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13023-023-02667-9","article-title":"Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review","volume":"18","author":"Gittus","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2025.123470_bb0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13023-018-0931-2","article-title":"Recommendations for the design of small population clinical trials","volume":"13","author":"Day","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2025.123470_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2024.104951","article-title":"Addressing diagnostic gaps and priorities of the global rare diseases community: recommendations from the IRDiRC diagnostics scientific committee","volume":"70","author":"Adams","year":"2024","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.jns.2025.123470_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2024.07.544","article-title":"460P understanding the clinical heterogeneity in myotonic dystrophy type 1: identifying clinical phenotypes using unsupervised clustering","volume":"43","author":"La Fontaine","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2025.123470_bb0255","series-title":"Splicing biomarkers of disease severity in myotonic dystrophy","author":"Nakamori","year":"2013"},{"key":"10.1016\/j.jns.2025.123470_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102338","article-title":"Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1","volume":"35","author":"Hicks","year":"2024","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.jns.2025.123470_bb0265","series-title":"Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy","author":"Tanner","year":"2021"},{"key":"10.1016\/j.jns.2025.123470_bb0270","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163856","article-title":"Individual transcriptomic response to strength training for myotonic dystrophy type 1 patients","volume":"8","author":"Davey","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jns.2025.123470_bb0275","series-title":"Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood","author":"van Cruchten","year":"2022"},{"key":"10.1016\/j.jns.2025.123470_bb0280","doi-asserted-by":"crossref","first-page":"g6802","DOI":"10.1136\/bmj.g6802","article-title":"Innovative research methods for studying treatments for rare diseases: methodological review","volume":"349","author":"Gagne","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2025.123470_bb0285","series-title":"Myotonic Dystrophy and Huntington\u2019s Disease Care: We Like to Think We\u2019re Making a Difference","author":"Ladonna","year":"2016"},{"key":"10.1016\/j.jns.2025.123470_bb0290","series-title":"Patient-Centered Therapy Development for Myotonic Dystrophy: Report of the Myotonic Dystrophy Foundation\u2013Sponsored Workshop","author":"Hesterlee","year":"2017"},{"key":"10.1016\/j.jns.2025.123470_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40900-023-00535-1","article-title":"Patient engagement in clinical trial design for rare neuromuscular disorders: impact on the DELIVER and ACHIEVE clinical trials","volume":"10","author":"Furlong","year":"2024","journal-title":"Res. Involv. Engagem."},{"key":"10.1016\/j.jns.2025.123470_bb0300","series-title":"Myotonic dystrophy patient preferences in patient-reported outcome measures","author":"Heatwole","year":"2018"},{"key":"10.1016\/j.jns.2025.123470_bb0305","series-title":"Analysis of the functional capacity outcome measures for myotonic dystrophy","author":"Jimenez-Moreno","year":"2019"},{"key":"10.1016\/j.jns.2025.123470_bb0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-018-0810-x","article-title":"Patient reported outcome measures in rare diseases: a narrative review","volume":"13","author":"Slade","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2025.123470_bb0315","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.3390\/ijms23094622","article-title":"Molecular therapies for myotonic Dystrophy type 1: from small drugs to gene editing","volume":"23","author":"Izzo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2025.123470_bb0320","doi-asserted-by":"crossref","first-page":"103489","DOI":"10.1016\/j.drudis.2023.103489","article-title":"The myotonic dystrophy type 1 drug development pipeline: 2022 edition","volume":"28","author":"Pascual-Gilabert","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jns.2025.123470_bb0325","series-title":"Avidity Biosciences, Orlando, Florida","article-title":"Initial Results of the Phase 2 Open-Label Extension Study of AOC 1001 in Adults With Myotonic Dystrophy Type 1: MARINA-OLE\u2122","author":"Johnson","year":"2024"},{"key":"10.1016\/j.jns.2025.123470_bb0330","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1212\/WNL.0000000000202529","article-title":"Preliminary Assessment of the Phase 1\/2 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Patients with Myotonic Dystrophy Type 1 (DM1) (MARINA) (S48.002)","volume":"100","author":"Johnson","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123470_bb0335","doi-asserted-by":"crossref","first-page":"104441.63","DOI":"10.1016\/j.nmd.2024.07.072","article-title":"221P initial data from the achieve trial of DYNE-101 in adults with myotonic dystrophy type 1 (DM1)","volume":"43","author":"Wolf","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2025.123470_bb0340","series-title":"Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1\/2a trial","author":"Thornton","year":"2023"},{"key":"10.1016\/j.jns.2025.123470_bb0345","doi-asserted-by":"crossref","first-page":"13359","DOI":"10.3390\/ijms232113359","article-title":"Recent Progress and challenges in the development of antisense therapies for myotonic Dystrophy type 1","volume":"23","author":"De Serres-B\u00e9rard","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2025.123470_bb0350","author":"NCT06138743"},{"key":"10.1016\/j.jns.2025.123470_bb0355","author":"NCT06667453"},{"key":"10.1016\/j.jns.2025.123470_bb0360","author":"CTIS2023-506028-10-00"},{"key":"10.1016\/j.jns.2025.123470_bb0365","author":"NCT06300307"},{"key":"10.1016\/j.jns.2025.123470_bb0370","series-title":"Time-Controlled and Muscle-Specific CRISPR\/Cas9-Mediated Deletion of CTG-Repeat Expansion in the DMPK Gene","author":"Cardinali","year":"2022"},{"key":"10.1016\/j.jns.2025.123470_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70227","article-title":"Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1","volume":"15","author":"Izzo","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jns.2025.123470_bb0380","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163856","article-title":"Individual transcriptomic response to strength training for myotonic dystrophy type 1 patients","volume":"8","author":"Davey","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jns.2025.123470_bb0385","article-title":"A systematic review of the barriers, enablers and strategies to embedding translational research within the public hospital system focusing on nursing and allied health professions","volume":"18","author":"Smith","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2025.123470_bb0390","doi-asserted-by":"crossref","first-page":"94","DOI":"10.31083\/j.jin2305094","article-title":"Bridging the gap: translational medicine and novel therapies in neuromuscular diseases","volume":"23","author":"Filosto","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.jns.2025.123470_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160475","article-title":"Optimising translational research opportunities: a systematic review and narrative synthesis of basic and clinician Scientists\u2019 perspectives of factors which enable or hinder translational research","volume":"11","author":"Fudge","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2025.123470_bb0400","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10198-023-01639-x","article-title":"Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy","volume":"25","author":"Michaeli","year":"2024","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.jns.2025.123470_bb0405","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/jpc.15507","article-title":"Rare diseases research and policy in Australia: on the journey to equitable care","volume":"57","author":"Bhattacharya","year":"2021","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.jns.2025.123470_bb0410","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41591-024-03369-w","article-title":"Can quantum computing crack the biggest challenges in health?","volume":"31","author":"Guenot","year":"2025","journal-title":"Nat. Med."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T16:14:09Z","timestamp":1744647249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":82,"alternative-id":["S0022510X25000875"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123470","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatments and therapies for symptoms and clinical manifestations of adult type 1 myotonic dystrophy: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123470"}}